# Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS

> **NCT00316732** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 173 (actual)

## Conditions studied

- Prostatic Hyperplasia

## Interventions

- **PROCEDURE:** IPSS Questionnaire
- **PROCEDURE:** EQ-5D Questionnaire

## Key facts

- **NCT ID:** NCT00316732
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10-25
- **Primary completion:** 2006-12-19
- **Final completion:** 2006-12-19
- **Target enrollment:** 173 (ACTUAL)
- **Last updated:** 2017-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00316732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00316732, "Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00316732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*